Por favor, use este identificador para citar o enlazar este ítem: http://ciatej.repositorioinstitucional.mx/jspui/handle/1023/797
Challenges for the development of dengue and zika virus vaccines
Abel Gutiérrez Ortega
DARWIN EDUARDO ELIZONDO QUIROGA
Acceso Abierto
Atribución-NoComercial-SinDerivadas
DOI: 10.26717/BJSTR.2018.08.001653
"Dengue (DENV) and Zika virus (ZIKV) are very close relatives belonging to the Flavivirus family and thus share many structural and antigenic features, as well as their infectious cycle. Both viruses are transmitted to humans through mosquito bites mainly from Aedes genus (Ae. aegypti and Ae. albopictus) [1], which have been expanded their habitats to an extent that half the World’s population is now at risk of DENV/ZIKV infection. The most severe consequences of having either virus would be dengue shock syndrome which normally leads to death [2], or in the case of ZIKV, microcephaly in newborns from infected mothers and GillianBarré syndrome [3-4]. For DENV, it has been well documented that a second infection with a different serotype, increases the chance of having the most severe dengue form, through a mechanism called antibody-dependent enhancement (ADE) [5], a phenomenon which has not been related in ZIKV infection in patients previously exposed to DENV or other Flaviviruses [6]. The fatal consequences, along with the lack of an effective treatment, have pushed forward a great effort from several research groups to develop vaccines against DENV, and it seems that some key learnings from DENV have accelerated the development for ZIKV vaccines".
Biomedical Journal of Scientific & Technical Research (BJSTR)
2018-08
Artículo
Biomedical Journal of Scientific & Technical Research (BJSTR)
Inglés
Bibliotecarios
Estudiantes
Investigadores
Maestros
MEDICINA Y CIENCIAS DE LA SALUD
Versión publicada
publishedVersion - Versión publicada
Aparece en las colecciones: ARTICULOS

Cargar archivos:


Fichero Tamaño Formato  
Challenges.pdf297.65 kBAdobe PDFVisualizar/Abrir